![Thomas Kerbusch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Kerbusch
Presidente presso Certara Strategic Consulting
Profilo
Thomas Kerbusch has worked as a Director at LA-SER Europe Ltd.
since 2018 and is currently employed there.
Additionally, he is currently working as the President at Certara Strategic Consulting.
Posizioni attive di Thomas Kerbusch
Società | Posizione | Inizio |
---|---|---|
LA-SER Europe Ltd.
![]() LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Direttore/Membro del Consiglio | 16/04/2018 |
Certara Strategic Consulting
![]() Certara Strategic Consulting Packaged SoftwareTechnology Services Certara Strategic Consulting provides drug development consultancy solutions. It also provides consulting services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company is headquartered in St. Louis, MO. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
LA-SER Europe Ltd.
![]() LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Health Technology |
Certara Strategic Consulting
![]() Certara Strategic Consulting Packaged SoftwareTechnology Services Certara Strategic Consulting provides drug development consultancy solutions. It also provides consulting services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company is headquartered in St. Louis, MO. | Technology Services |
- Borsa valori
- Insiders
- Thomas Kerbusch